Monographie - Morphine tartrate - Stabilis 4.0

Last update :
19/11/2024

Analgesic

Morphine tartrate

injection

Stability in solutions

Stability of mixtures

Factors which affect stability

Compatibility

Route of administration

References

pdf

Chemical structure

Tradename

Tradename

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Morphine tartrate

Australia

References

injection

References : Morphine tartrate

	Type	Publication
519	Journal	Poggi GL. Compatibility of morphine tartrate admixtures in polypropylene syringes. Aust J Hosp Pharm 1991 ; 21: 316.
920	Journal	Targett PL, Keefe PA, Merridew CG. Stability of two concentrations of morphine tartrate in 10 mL polypropylene syringes. Aust J Hosp Pharm 1997 ; 27: 452-454.
980	Journal	Ambados F. Compatibility of morphine and ketamine for subcutaneous infusion. Aust J Hosp Pharm 1995 ; 25: 352.
1864	Journal	Lau MH, Hackman C, Morgan DJ. Compatibility of ketamine and morphin injections. Pain 1998 ; 75: 389-390.
2083	Journal	La Forgia SP, Sharley NA, Burgess NG, Doecke CJ. Stability and compatibility of morphine, midazolam and bupivacaine combinaisons for iontravenous infusion. J Pharm Pract and Res 2002 ; 32: 65-68.
3474	Manufacturer	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3504	Manufacturer	Parecoxib (Dynastat®) - Summary of Product Characteristics Pfizer 2012
3644	Manufacturer	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010
3675	Manufacturer	Thiopental sodium - Summary of Product Characteristics Archimedes Pharma UK Ltd 2015
3838	Manufacturer	Magnesium Sulphate - Summary of Product Characteristics Martindale Pharmaceuticals Ltd 2007
3934	Manufacturer	Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit GlaxoSmithKline Laboratoire 2016

Mentions Légales